Form 4: DarioHealth Director Jon Kaplan Acquires 30,000 Shares of Common Stock
SEC Form 4 Filing
Jon H. Kaplan, a director of DarioHealth Corp., acquired 30,000 shares of common stock on February 24, 2025.
Summary
- On February 24, 2025, Jon H. Kaplan, a director of DarioHealth Corp., acquired 30,000 shares of common stock.
- The acquisition was a direct transaction.
- Following the transaction, Kaplan directly owns 111,574 shares of DarioHealth Corp.
- The transaction was reported on February 25, 2025.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing, indicating a neutral sentiment. It simply reports a transaction.
Positives
- A director's increased stake in the company may signal confidence in its future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction could influence investor sentiment regarding DarioHealth Corp.
Key Dates
| Date | Description |
|---|---|
| 02/24/2025 | Date of transaction: Jon Kaplan acquired 30,000 shares of common stock. |
| 02/25/2025 | Date of report: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.